Skip to main content
BIOX
NASDAQ Industrial Applications And Services

Bioceres Subsidiaries' Collateral Foreclosed for $15M Amidst Disputed Defaults

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Industrial
Sentiment info
Negative
Importance info
9
Price
$1.3
Mkt Cap
$82.197M
52W Low
$1.17
52W High
$7.438
52W Position info
11% above low
Off High info
83% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

BIOX is trading near its 52-week low of $1.17 (11% above the low) on light trading volume (0.4× avg).

Summary

Bioceres Crop Solutions Corp. announced that collateral from its Pro Farm Group subsidiaries was foreclosed and sold for $15 million to noteholders, a transaction the company disputes.


Key Events · Legal and Risk Events · BIOX

  • UCC Foreclosure Sale

    A UCC foreclosure sale was held on January 20, 2026, concerning collateral pledged by Bioceres' subsidiaries, Pro Farm Group, Inc. and Pro Farm Michigan Manufacturing, LLC, due to alleged defaults on notes.

  • Collateral Acquired by Noteholders' Joint Venture

    PFG Holdings Corp., a joint venture formed by the noteholders, was the sole qualified bidder and acquired the collateral with a credit bid of $15 million in notes held.

  • Company Disputes Foreclosure

    Bioceres Crop Solutions Corp. disputes the alleged defaults that led to the foreclosure and the commercial reasonableness of the sale, reserving all rights and remedies.


Analysis · BIOX · Industrial Applications And Services

This event signals significant financial distress and potential loss of key assets for Bioceres Crop Solutions Corp. The $15 million foreclosure sale, representing a substantial portion of the company's market capitalization, indicates a material impact on its financial health and operational capacity. The company's dispute over the alleged defaults and the commercial reasonableness of the sale suggests ongoing legal battles and uncertainty, which could further impact investor confidence and financial stability. Investors should monitor the outcome of these disputes and assess the long-term implications for the company's asset base and future operations.

At the time of this filing, BIOX was trading at $1.30 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $82.2M. The 52-week trading range was $1.17 to $7.44. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BIOX - Latest Insights

BIOX
Jul 07, 2026, 7:08 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $0.3294
Real-time Price: $0.343 info
Change: +$0.0136 (+4%) info
Market Cap: $21.687M info
BIOX
Jun 22, 2026, 6:04 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.3726
Real-time Price: $0.343 info
Change: -$0.0296 (-8%) info
Market Cap: $21.687M info
BIOX
Jun 01, 2026, 5:16 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $0.4837
Real-time Price: $0.343 info
Change: -$0.1407 (-29%) info
Market Cap: $21.687M info
BIOX
Jun 01, 2026, 10:16 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.4338
Real-time Price: $0.343 info
Change: -$0.0908 (-21%) info
Market Cap: $21.687M info
BIOX
May 12, 2026, 4:01 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.451
Real-time Price: $0.343 info
Change: -$0.108 (-24%) info
Market Cap: $21.687M info